EDE
Tech / AI / DefenseDOWNTREND$0.105
as of 2026-07-27
5d return
-8.7%
20d return
-27.6%
60d return
-44.7%
RSI 14
37.5
vs 52w high
-59.6%
vs 52w low
+377.3%
SMA 20
Below
SMA 50
Below
Eden is securing multi-state equipment rollout from major customer Amrize (NYSE: AMRZ, ~19,000 employees), indicating validated product traction and potential for recurring supply revenue. However, the US$32k initial order is modest in absolute terms relative to a $73m market cap, and the announcement lacks detail on equipment capex, installation timeline, or volume ramp potential.
EdenCrete has achieved positive trial results with the Indian government, indicating potential traction in a large emerging-market infrastructure sector. Without detail on scale, timeline to commercialisation, or revenue impact, the announcement appears exploratory rather than revenue-material at this stage.
UBS has fully exited its substantial holding in Eden Innovations through a series of sells and a rehypothecated position return, suggesting opportunistic or portfolio-driven liquidation rather than operational concern. The exit follows a 19% share price decline over 20 days, positioning UBS's exit as a trailing move into weakness.